Learn more

HEGER PETER

Overview
  • Total Patents
    27
About

HEGER PETER has a total of 27 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, Germany and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and consumer goods are RIEPMA KLAAS ALOUIS, BLIGHT ANDREW R and CORTICE BIOSCIENCES INC.

Patent filings per year

Chart showing HEGER PETERs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Heger Peter 24
#2 Spaich Carl-Friedrich 23
#3 Rettenberger Reinhard 22
#4 Carl-Friedrich Spaich 3
#5 Reinhard Rettenberger 3
#6 Peter Heger 3
#7 Dr Rettenberger Reinhard 1

Latest patents

Publication Filing date Title
DE102009004603A1 Outer wear e.g. shirt, for use during sporting event, has individual removable parts detachably connected with each other by connecting elements such as hook and loop fastener, snap fastener and adhesive
CA2596178A1 Method for producing a drug extract that contains hydroxystilbene
US2009042817A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
AU2006210118A1 Use of active ingredients containing hydroxystilbene for preventing and/or treating osteoporosis
DE102005005275A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression
DE102005005274A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression
DE102005005270A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression
DE102005005276A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression